Literature DB >> 7776115

Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures.

M Uhari1, H Rantala, L Vainionpää, R Kurttila.   

Abstract

Acetaminophen and low doses of diazepam were evaluated for the prevention of recurrences of febrile seizures in a placebo-controlled, double-blind trial. Children after their first febrile seizure were assigned to receive either one dose of rectally administered diazepam, and then, after 6 hours, oral doses of 0.2 mg/kg three times a day for the first 2 days if the fever stayed greater than 38.5 degrees C, or a placebo similarly during forthcoming febrile episodes. In addition, each febrile episode was randomly assigned to be treated with acetaminophen or the placebo. Thus four groups were examined for 2 years: patients receiving two kinds of placebo, patients receiving diazepam and a placebo, patients receiving acetaminophen and a placebo, and patients receiving both diazepam and acetaminophen. Of a total of 180 patients (102 boys), 161 were followed for the 2-year period and 157 were seen at the last outpatient examination: 80 in the diazepam group and 77 in the placebo group. The final analysis of the efficacy of the drugs was made on the basis of the data from 153 patients who had had at least one febrile episode during follow-up. There were 641 fever events during this period, and 38 children (21.1%) had 55 recurrences of febrile seizures. Acetaminophen had no effect on the recurrence rate. Seizures recurred at least once in 21 patients (28.4%) receiving diazepam and 17 (21.5%) receiving a placebo (p = 0.4138, log-rank test). The combination of antipyretic agents with anticonvulsant medication did not reduce the recurrence of febrile seizures. Our results show that low doses of acetaminophen or diazepam or both are ineffective for preventing febrile seizures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776115     DOI: 10.1016/s0022-3476(95)70231-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Randomised controlled trial of combined paracetamol and ibuprofen for fever.

Authors:  M D S Erlewyn-Lajeunesse; K Coppens; L P Hunt; P J Chinnick; P Davies; I M Higginson; J R Benger
Journal:  Arch Dis Child       Date:  2006-02-07       Impact factor: 3.791

2.  Paracetamol for feverish children: parental motives and experiences.

Authors:  Janne Fangel Jensen; Louise Lindhardt Tønnesen; Margareta Söderström; Hanne Thorsen; Volkert Siersma
Journal:  Scand J Prim Health Care       Date:  2010-06       Impact factor: 2.581

3.  Fever--concepts old and new.

Authors:  I Blumenthal
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

4. 

Authors:  Nicholas Monfries; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

Review 5.  Prevention and management of febrile seizures.

Authors:  R J Baumann
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Prophylactic drug management for febrile seizures in children.

Authors:  Martin Offringa; Richard Newton; Martinus A Cozijnsen; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2017-02-22

Review 7.  Assessment of febrile seizures in children.

Authors:  Arne Fetveit
Journal:  Eur J Pediatr       Date:  2007-09-02       Impact factor: 3.183

8.  Informed consent, parental awareness, and reasons for participating in a randomised controlled study.

Authors:  M van Stuijvenberg; M H Suur; S de Vos; G C Tjiang; E W Steyerberg; G Derksen-Lubsen; H A Moll
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

Review 9.  The role of interleukin-1beta in febrile seizures.

Authors:  James G Heida; Solomon L Moshé; Quentin J Pittman
Journal:  Brain Dev       Date:  2009-02-13       Impact factor: 1.961

Review 10.  Paracetamol for treating fever in children.

Authors:  M Meremikwu; A Oyo-Ita
Journal:  Cochrane Database Syst Rev       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.